31 now in ICU. Time 4 2 use 'Special Access Scheme' 2 facilitate Remestemcel-L use 4 Covid-19 intubated patients facing ~80% mortality. Victorians need & deserve every available option...Quote TweetPeter· 14 Jul@DanielAndrewsMP W/- 21 intubated patients U need 2 talk 2 @Mesoblast NOW. Remestemcel_L: 1)Mt Saini NY trial Apr20 83% recovery. 2)n=300 US FDA funded trial underway. 3)Compassionate use 4 US kids w/- Covid complications. Do ur homework & go 4 a walk Dan! Meso: L38, 55 CollinsSt
Cell Therapy News/Articles, page-4568
-
- There are more pages in this discussion • 13,678 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.13 |
Change
0.035(3.21%) |
Mkt cap ! $1.284B | |||
| Open | High | Low | Value | Volume |
| $1.09 | $1.13 | $1.07 | $3.910M | 3.535M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 27197 | $1.11 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.13 | 43578 | 3 |
View Market Depth
| Last trade - 16.10pm 27/09/2024 (20 minute delay) ? |
| MSB (ASX) Chart |